CCM
ABBV icon

Colorado Capital Management’s AbbVie ABBV Stock Holding History

Colorado Capital Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-805
Closed -$184K – 106
2025
Q4 		$184K Sell
805
-82
-9% -$18.7K 0.07% 105
2025
Q3 		$205K Sell
887
-241
-21% -$49.1K 0.08% 102
2025
Q2 		$209K Buy
1,128
+2
+0.2% +$372 0.09% 96
2025
Q1 		$236K Hold
1,126
– – 0.11% 90
2024
Q4 		$200K Sell
1,126
-250
-18% -$46K 0.1% 90
2024
Q3 		$272K Sell
1,376
-780
-36% -$146K 0.13% 83
2024
Q2 		$370K Buy
2,156
+671
+45% +$111K 0.21% 78
2024
Q1 		$270K Buy
1,485
+111
+8% +$19.1K 0.16% 79
2023
Q4 		$213K Hold
1,374
– – 0.14% 73
2023
Q3 		$205K Sell
1,374
-12
-0.9% -$1.76K 0.16% 76
2023
Q2 		$186K Buy
1,386
+12
+0.9% +$1.76K 0.14% 73
2023
Q1 		$219K Sell
1,374
-133
-9% -$20.3K 0.17% 73
2022
Q4 		$243K Buy
1,507
+133
+10% +$20.4K 0.2% 68
2022
Q3 		$184K Hold
1,374
– – 0.16% 67
2022
Q2 		$210K Sell
1,374
-130
-9% -$19.9K 0.17% 66
2022
Q1 		$243K Sell
1,504
-56
-4% -$8.13K 0.17% 67
2021
Q4 		$212K Buy
+1,560
New +$184K 0.14% 74

Other funds holding ABBV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Colorado Capital Management's ABBV Position: Q1 2026 in Review

Colorado Capital Management sold out of AbbVie (ABBV) in Q1 2026, closing a stake of 805 shares — an estimated $184K sold.

Colorado Capital Management first reported a position in ABBV in Q4 2021 and held it in 17 quarters. The position peaked at $370K in Q2 2024. 4,080 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.

  • Colorado Capital Management reported no remaining AbbVie position as of Q1 2026 after selling out during the quarter.
  • Colorado Capital Management sold 805 AbbVie shares in Q1 2026, an estimated $184K.
  • Colorado Capital Management first reported a position in AbbVie in Q4 2021 and held it in 17 quarters.
  • Colorado Capital Management's AbbVie position peaked at $370K in Q2 2024.
  • 4,080 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.

Based on Colorado Capital Management's 13F filing for Q1 2026, filed 14 Apr 2026.